Bookmark Email Print page

Optimize cost efficiency

Industry challenges

The penetration of generic and  the end of patent’s protection for major blockbusters (65 billion off patent by 2012)* urges cost reduction & strengthening of the pipeline. The pressure on costs will induce the implementation of a new organizational model characterized by more analytical and value adding activities and a higher level of shared processes.

The frequency & diversity of governmental interventions increases difficulty to predict future earnings and require increased strategic flexibility.
The import/export patterns and the counterfeiting urges the review of the traditional supply chain model.

In order to face these industry challenges, most companies will need to answer the following key questions:

Key questions: How can we optimize...

  • Financial services (Target operating model, shared services)
  • Performance management (costing model, planning, dashboard,…)
  • Our working capital
  • Our supply chain offering
  • Clinical development costs (Investigators, patients insurances, safety, regulations)
  • Infrastructure

Deloitte offering - selected approaches & credentials

Deloitte has helped several big Life Sciences companies in:

  • Building shared service centers
  • Conducting adding value benchmarking analysis.
  • Financial Organisational Review / Shared Services
  • Financial Process Review
  • Outsourcing Advisory
  • Dashboard implementation
  • BI Implementation
  • Planning Budgeting and Forecasting
  • Activity Based Costing

*82 billion in sales is at risk through 2014 (source: datamonitor)

 

Related link

  • Health sciences & health care
    Shaping the evolution of the industry.

More Learn more